Become the Partner of Choice With Our Market Expansion Opportunities to Unlock the High Value Korean TPD Market
Asia is rapidly becoming one of the most competitive and strategically important regions for TPD innovation, and South Korea is at the center of that momentum. As the third‑largest biopharma hub globally, Korea is accelerating breakthroughs in novel small‑molecule design, AI‑enabled degrader discovery, and induced proximity therapeutics.
With more TPD companies entering the region and Korean innovators actively seeking global partners, this is a pivotal moment to establish yourself early as the scientific and strategic ally that emerging players trust.
Why Korea Is Becoming the Go To Expansion Market for Degraders
Korea’s rapidly advancing R&D infrastructure and growing appetite for differentiated therapeutic modalities are drawing global attention from TPD companies seeking:
- Access to a fast‑expanding early‑stage pipeline powered by competitive research institutions and a young biotech-led industry
- New licensing and co‑development opportunities fueled by Korea’s strong commercialization focus and pharma involvement
- High‑throughput screening platforms within a region are eager to adopt cutting‑edge drug discovery platforms
- Proximity to an Asia‑Pacific ecosystem that is heavily investing in induced proximity and next‑generation therapeutics
For international companies, Korea offers a rare combination of market openness, scientific sophistication, and ROI‑driven partnership potential.
Meet the Innovators Driving TPD Forward in Asia
By partnering with the World TPD & Induced Proximity Summit South Korea, you also gain access to the broader World Targeted Therapeutics Summit South Korea, a combined platform uniting global decision‑makers across degraders, ADCs, and bispecific modalities.
This is one of the only opportunities in Asia to:
- Engage directly with Korean innovators shaping newly expanded TPD pipelines
- Connect with global leaders traveling in from the US, EU, Japan, and broader APAC
- Position yourself in front of companies actively seeking collaborators, assay partners, structural insights, and enabling technologies
In Korea, face‑to‑face relationship building is still one of the strongest drivers of partnerships, licensing discussions, and long‑term commercial collaboration, and this summit places you directly in front of decision makers looking for partnerships.
Why Partner With Us?
- Establish Yourself as Korea’s Partner of Choice
Become the go‑to provider for Korean TPD companies seeking reliable assay developers, structural biology expertise, platform partners, and mechanistic insight as they expand their pipelines
- Engage 30+ Korean Companies Across the Full Value Chain
Showcase your capabilities to organizations spanning early R&D, platform technology, translational development, and business development, each evaluating partners to propel their TPD programs forward
- Build Regional Credibility Through In‑Person Engagement
Strengthen brand visibility and demonstrate your commitment to the Korean market through high‑value, face‑to‑face networking with leaders who prioritize trusted, ongoing relationships
- Maximize Sponsor ROI in a Market Hungry for Partnerships
Korea’s licensing appetite, competitive biotech sector, and early‑stage degrader pipelines make it one of the highest‑ROI geographies for platform and service providers
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.